Impact of NRAS mutation on efficacy of triplet induction therapy in newly diagnosed multiple myeloma

被引：0
|
作者：
Mishima, Yuko [1 ,2 ]
Shirouchi, Yuko [1 ]
Takayama, Tomoko [2 ]
Minowa, Sayuri [2 ]
Ishihara, Yuko [1 ]
Hirano, Kei [1 ]
Hirano, Mitsuhito [1 ]
Yoshida, Kikuaki [1 ]
Teramoto, Yukako [1 ]
Yamauchi, Nobuhiko [1 ]
Low, Siew-Kee [3 ]
Maruyama, Dai [1 ]
机构：
[1] Canc Inst Hosp, Japanese Fdn Canc Res, Dept Hematol Oncol, 3-8-31 Ariake,Koto Ku, Tokyo 1358550, Japan
[2] Japanese Fdn Canc Res, Canc Chemotherapy Ctr, Div Clin Res, Tokyo, Japan
[3] Japanese Fdn Canc Res, Canc Precis Med Ctr, Liquid Biopsy Diag Dev Project, Tokyo, Japan
来源：
JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY | 2025年 / 65卷 / 01期
关键词：
multiple myeloma; somatic mutation; prognostic factor; NRAS; INTERNATIONAL STAGING SYSTEM;
D O I：
10.3960/jslrt.24077
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：72 / 76
页数：5
相关论文
共 50 条
  • [1] Induction Therapy for Newly Diagnosed Multiple Myeloma
    Lonial, Sagar
    San Miguel, Jesus F.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2013, 11 (01): : 19 - 28
  • [2] Efficacy of induction with cybord in newly diagnosed multiple myeloma
    Reeder, C. B.
    Stewart, A. K.
    Hentz, J. G.
    Bergsagel, P. L.
    Pirooz, N. A.
    Fonseca, R.
    Chen, C.
    Trudel, S.
    Reece, D.
    Kukreti, V.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [3] Body Mass Index Trajectory during Triplet Induction Therapy: Clinical Implications in Newly Diagnosed Multiple Myeloma
    Thirugnanasambandam, Ram Prakash
    Firestone, Ross S.
    Derkach, Andriy
    Furberg, Helena
    Shekarkhand, Tala
    Rueda, Colin
    Maclachlan, Kylee H.
    Hultcrantz, Malin
    Mailankody, Sham
    Patel, Dhwani
    Lahoud, Oscar Boutros
    Landau, Heather J.
    Chung, David J.
    Shah, Gunjan L.
    Scordo, Michael
    Hassoun, Hani
    Lesokhin, Alexander M.
    Giralt, Sergio
    Korde, Neha
    Usmani, Saad Z.
    Tan, Carlyn Rose
    Shah, Urvi A.
    BLOOD, 2024, 144 : 6948 - 6949
  • [4] Induction Therapy and Stem Cell Mobilization in Patients with Newly Diagnosed Multiple Myeloma
    Ria, Roberto
    Reale, Antonia
    Solimando, Antonio Giovanni
    Mangialardi, Giuseppe
    Moschetta, Michele
    Gelao, Lucia
    Iodice, Giuseppe
    Vacca, Angelo
    STEM CELLS INTERNATIONAL, 2012, 2012
  • [5] Hemostasis in Newly Diagnosed Multiple Myeloma Patients before and after Induction Therapy
    Urnova, Evdokia S.
    Mendeleeva, Larisa P.
    Pokrovskaya, Olga S.
    Gracheva, Marina A.
    Gemdzhian, Eduard G.
    Kuzmina, Larisa A.
    Tarandovsky, Ivan D.
    Firsova, Maiia V.
    Nareiko, Mariya V.
    Seregina, Elena A.
    Balandina, Anna N.
    Ataullakhanov, Fazoil I.
    Vasil'ev, Sergei A.
    Savchenko, Valeri G.
    BLOOD, 2015, 126 (23)
  • [6] Changes in uninvolved immunoglobulins during induction therapy for newly diagnosed multiple myeloma
    Ravi, P.
    Kumar, S.
    Gonsalves, W.
    Buadi, F.
    Lacy, M. Q.
    Go, R. S.
    Dispenzieri, A.
    Kapoor, P.
    Lust, J. A.
    Dingli, D.
    Lin, Y.
    Russell, S. J.
    Leung, N.
    Gertz, M. A.
    Kyle, R. A.
    Bergsagel, P. L.
    Rajkumar, S. V.
    BLOOD CANCER JOURNAL, 2017, 7 : e569 - e569
  • [7] Changes in uninvolved immunoglobulins during induction therapy for newly diagnosed multiple myeloma
    P Ravi
    S Kumar
    W Gonsalves
    F Buadi
    M Q Lacy
    R S Go
    A Dispenzieri
    P Kapoor
    J A Lust
    D Dingli
    Y Lin
    S J Russell
    N Leung
    M A Gertz
    R A Kyle
    P L Bergsagel
    S V Rajkumar
    Blood Cancer Journal, 2017, 7 : e569 - e569
  • [8] Clinical significance of baseline body mass index and its trajectory during triplet induction therapy in newly diagnosed multiple myeloma
    Thirugnanasambandam, Ram Prakash
    Firestone, Ross
    Derkach, Andriy
    Maclachlan, Kylee
    Hultcrantz, Malin
    Mailankody, Sham
    Lahoud, Oscar
    Landau, Heather
    Chung, David
    Shah, Gunjan
    Scordo, Michael
    Hassoun, Hani
    Lesokhin, Alexander
    Giralt, Sergio
    Korde, Neha
    Usmani, Saad
    Tan, Carlyn Rose
    Shah, Urvi
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S307 - S308
  • [9] Impact of Improvement in Renal Function and Waiting Time Before Induction Therapy on Survival in Newly Diagnosed Multiple Myeloma
    Wohner, Nikolett
    Varga, Gergely
    Farkas, Peter
    Horvath, Laura
    Szombath, Gergely
    Varkonyi, Judit
    Masszi, Tamas
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S322 - S322
  • [10] Lenalidomide, Bortezomib, and Dexamethasone (RVD) As Induction Therapy in Newly Diagnosed Multiple Myeloma (MM)
    Joseph, Nisha
    Almaula, Dhwani
    Gleason, Charise
    Heffner, Leonard
    Boise, Lawrence H.
    Kaufman, Jonathan L.
    Lonial, Sagar
    Nooka, Ajay
    BLOOD, 2017, 130
12345